Presence of the HMOX1 L allele did not affect serum bilirubin concentrations, but as expected UGT1A1 (TA)7 gene variation significantly increased serum bilirubin concentrations in both NAFLD patients and controls (Table 2). The gene discussed is UGT1A1; the disease is metabolic dysfunction-associated steatotic liver disease.